Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shouhui capsule for constipation related to putelimab-based systemic therapy in MSS advanced colorectal cancer
ChiCTR2600135250Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Dec 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of shouhui tongbian and pucotenlimab in constipation (2 arms), sponsored by Shanghai General Hospital. Primary endpoints: Improvement in defecation frequency and Types and severity of side effects. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
shouhui tongbianpucotenlimab
03
Conditions
constipation
Beyond the preview
Go deeper on ChiCTR2600135250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135250.